Discrimination Of NASDAQ OCGN And Its Discrimination
Ocugen Inc. (NASDAQ OCGN at https://www.webull.com/quote/nasdaq-ocgn) Ocugen may be a clinical-stage research institute designing a series of imaginative therapies that target rare and disadvantaged common ailments. Earned 34.38% to close Wednesday’s (Oct.9) trade at $1.72. News: The Company has been approved by its Board of Directors to re – purchase offers of up to $2 million in respect of its